1 | ANTI-VON willebrand factor nanobody, caplacizumab | - | - | - | - | 1件: 64 64 💬
|
2 | ANTI-VON willebrand factor nanobody, INN = caplacizumab | 1件: Caplacizumab Caplacizumab (Caplacizumab) | 1件: Caplacizumab
Caplacizumab
(Caplacizumab, Caplacizumab, Caplacizumab-yhdp) 💬
| 1件: VWF VWF 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬
|
3 | Caplacizumab | 1件: Caplacizumab Caplacizumab (Caplacizumab) | 1件: Caplacizumab
Caplacizumab
(Caplacizumab, Caplacizumab, Caplacizumab-yhdp) 💬
| 1件: VWF VWF 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 2件: 63 63, 64 💬
|